These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 17429057)
1. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase. Schaefer U; Vorlova S; Machida T; Melchor JP; Strickland S; Levi R J Pharmacol Exp Ther; 2007 Jul; 322(1):265-73. PubMed ID: 17429057 [TBL] [Abstract][Full Text] [Related]
2. The plasminogen activator system modulates sympathetic nerve function. Schaefer U; Machida T; Vorlova S; Strickland S; Levi R J Exp Med; 2006 Sep; 203(9):2191-200. PubMed ID: 16940168 [TBL] [Abstract][Full Text] [Related]
3. Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice. Lijnen HR; Moons L; Beelen V; Carmelie P; Collen D Thromb Haemost; 1995 Oct; 74(4):1126-31. PubMed ID: 8560424 [TBL] [Abstract][Full Text] [Related]
4. Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesity. Morange PE; Bastelica D; Bonzi MF; Van Hoef B; Collen D; Juhan-Vague I; Lijnen HR Thromb Haemost; 2002 Feb; 87(2):306-10. PubMed ID: 11858492 [TBL] [Abstract][Full Text] [Related]
5. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury. Matsuno H; Kozawa O; Niwa M; Ueshima S; Matsuo O; Collen D; Uematsu T Thromb Haemost; 1999 Apr; 81(4):601-4. PubMed ID: 10235447 [TBL] [Abstract][Full Text] [Related]
6. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Declerck PJ; Verstreken M; Collen D Thromb Haemost; 1995 Nov; 74(5):1305-9. PubMed ID: 8607114 [TBL] [Abstract][Full Text] [Related]
7. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice. de Vries TJ; Kitson JL; Silvers WK; Mintz B Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649 [TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells. Ueshima S; Fukao H; Okada K; Matsuo O Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564 [TBL] [Abstract][Full Text] [Related]
9. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes. Lijnen HR; Wagner EF; Collen D Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597 [TBL] [Abstract][Full Text] [Related]
10. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation. Cook AD; Vlahos R; Massa CM; Braine EL; Lenzo JC; Turner AL; Way KJ; Hamilton JA Thromb Haemost; 2006 Apr; 95(4):659-67. PubMed ID: 16601837 [TBL] [Abstract][Full Text] [Related]
11. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444 [TBL] [Abstract][Full Text] [Related]
12. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro. Paciucci R; Torà M; Díaz VM; Real FX Oncogene; 1998 Feb; 16(5):625-33. PubMed ID: 9482108 [TBL] [Abstract][Full Text] [Related]
13. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition. Kaikita K; Schoenhard JA; Painter CA; Ripley RT; Brown NJ; Fogo AB; Vaughan DE J Mol Cell Cardiol; 2002 Jun; 34(6):617-27. PubMed ID: 12054849 [TBL] [Abstract][Full Text] [Related]
14. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma. Häckel C; Czerniak B; Ayala AG; Radig K; Roessner A Cancer; 1997 Jan; 79(1):53-8. PubMed ID: 8988726 [TBL] [Abstract][Full Text] [Related]
15. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor? Camani C; Gavin O; Kruithof EK Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388 [TBL] [Abstract][Full Text] [Related]
16. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes. Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells. Kuiper J; Otter M; Voorschuur AH; van Zonneveld AJ; Rijken DC; van Berkel TJ Thromb Haemost; 1995 Nov; 74(5):1298-304. PubMed ID: 8607113 [TBL] [Abstract][Full Text] [Related]
18. Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis. Cook AD; Braine EL; Campbell IK; Hamilton JA Am J Pathol; 2002 Mar; 160(3):917-26. PubMed ID: 11891190 [TBL] [Abstract][Full Text] [Related]
19. Relationship between circulating plasminogen activators and tumor development in mice. Colombi M; Rebessi L; Boiocchi M; Barlati S Cancer Res; 1986 Nov; 46(11):5748-53. PubMed ID: 3093069 [TBL] [Abstract][Full Text] [Related]
20. Tissue-type plasminogen activator depletion affects the nasal mucosa matrix reconstruction in allergic rhinitis mice. Hua H; Zhang R; Yu S; Wang H; Zhao Y; Yu S; Li W Allergol Immunopathol (Madr); 2011; 39(4):206-11. PubMed ID: 21339035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]